Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

157 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Efficacy of mepolizumab in usual clinical practice and characteristics of responders.
Rodríguez-García C, Blanco-Aparicio M, Nieto-Fontarigo JJ, Blanco-Cid N, Gonzalez-Fernandez C, Mosteiro-Añon M, Calvo-Alvarez U, Perez-De-Llano L, Corbacho-Abelaira MD, Lourido-Cebreiro T, Dominguez-Juncal LM, Crespo-Diz C, Dacal-Quintas R, Pallares-Sanmartin A, Dacal-Rivas D, Gonzalez-Barcala FJ. Rodríguez-García C, et al. Respir Med. 2021 Oct;187:106595. doi: 10.1016/j.rmed.2021.106595. Epub 2021 Sep 2. Respir Med. 2021. PMID: 34492540 Free article.
Asthma-COPD overlap: identification and optimal treatment.
Cosío BG, Dacal D, Pérez de Llano L. Cosío BG, et al. Ther Adv Respir Dis. 2018 Jan-Dec;12:1753466618805662. doi: 10.1177/1753466618805662. Ther Adv Respir Dis. 2018. PMID: 30336736 Free PMC article. Review.
A Simple Score for Future Risk Prediction in Patients with Controlled Asthma Who Undergo a Guidelines-Based Step-Down Strategy.
Pérez de Llano L, García-Rivero JL, Urrutia I, Martínez-Moragón E, Ramos J, Cebollero P, Carballada F, Blanco-Aparicio M, Vennera MDC, Merino M, Torralba-García Y, Plaza V. Pérez de Llano L, et al. J Allergy Clin Immunol Pract. 2019 Apr;7(4):1214-1221.e3. doi: 10.1016/j.jaip.2018.10.017. Epub 2018 Oct 25. J Allergy Clin Immunol Pract. 2019. PMID: 30368006
Unmet therapeutic goals and potential treatable traits in a population of patients with severe uncontrolled asthma in Spain. ENEAS study.
Pérez de Llano L, Martínez-Moragón E, Plaza Moral V, Trisan Alonso A, Sánchez CA, Callejas FJ, Vera E, Soto Campos JG, Martinez Rivera C, Alcázar Navarrete B, Urrutia Landa I, Garcia Rivero JL, Padilla Galo A, Alvarez Gutierrez F, Landete P, Ramos González J, Aracil CF, Carretero Gracia JÁ, Lluch I, Puente L, Andujar-Espinosa R, Cosío BG. Pérez de Llano L, et al. Respir Med. 2019 May;151:49-54. doi: 10.1016/j.rmed.2019.03.006. Epub 2019 Apr 1. Respir Med. 2019. PMID: 31047117 Free article. No abstract available.
Efficacy and safety of treatment with biologicals (benralizumab, dupilumab, mepolizumab, omalizumab and reslizumab) for severe eosinophilic asthma. A systematic review for the EAACI Guidelines - recommendations on the use of biologicals in severe asthma.
Agache I, Beltran J, Akdis C, Akdis M, Canelo-Aybar C, Canonica GW, Casale T, Chivato T, Corren J, Del Giacco S, Eiwegger T, Firinu D, Gern JE, Hamelmann E, Hanania N, Mäkelä M, Hernández-Martín I, Nair P, O'Mahony L, Papadopoulos NG, Papi A, Park HS, Pérez de Llano L, Posso M, Rocha C, Quirce S, Sastre J, Shamji M, Song Y, Steiner C, Schwarze J, Alonso-Coello P, Palomares O, Jutel M. Agache I, et al. Allergy. 2020 May;75(5):1023-1042. doi: 10.1111/all.14221. Epub 2020 Feb 24. Allergy. 2020. PMID: 32034960
Distilling Fact from the Vapor of Nuance: Asthma Exacerbations.
Pérez de Llano L, Dacal-Rivas D, Blanco-Cid N, Martín-Robles I. Pérez de Llano L, et al. J Allergy Clin Immunol Pract. 2021 Feb;9(2):842-843. doi: 10.1016/j.jaip.2020.10.007. J Allergy Clin Immunol Pract. 2021. PMID: 33551042 No abstract available.
157 results